Prostate cancer is one of the leading cancers in men and more than 43000 cases were reported in India in 2022 as per the National Cancer Registry Program of India. Prostate cancer growth is majorly driven by the male hormone, testosterone, a member of ‘Androgens’. So, one of the key strategies of prostate cancer management is ‘Androgen Deprivation Therapy (ADT)’ with a goal of suppressing testosterone levels. It can be achieved by surgery or by using drugs. The duration of ADT depends on the disease status. The drugs currently used for treatment are all injectables with different routes of administration (in muscle or under the skin) and could be done only under the supervision of a care giver.

Relugolix is reportedly the only oral option of ADT drugs known as gonadotropin releasing hormone (GnRH) analogues with its launch globally in 2020.

Relugolix is available in India on request-

Lucknow Speciality Pharma is the leading Pharma brand and one of the most leading Pharma Wholesalers in Lucknow. We are expanding our reach across India. To get “Rexigo (Relugolix) Tablets“, patients can simply fill the order form or can send mail at info@lucknowpharma.com. Patients can also send WhatsApp messages to +91-9555306364, The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.